Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Metabolic acidosis is a common complication in chronic kidney disease (CKD) patients, and is associated with an accelerated decline in renal function. Oral bicarbonate therapy has been used to counteract metabolic acidosis in CKD for decades. However, until recently, there have been very few interve...
Main Authors: | May Khei Hu, Miles D. Witham, Roy L. Soiza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/2/208 |
Similar Items
-
High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2013-01-01) -
Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT
by: Miles D Witham, et al.
Published: (2020-06-01) -
Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease
by: Keiji Hirai, et al.
Published: (2019-09-01) -
Defining features in the kinetics of sodium carbonate-bicarbonate solution carbonization and the quality of the resulting sodium bicarbonate crystals
by: Mykola Porokhnia, et al.
Published: (2021-08-01) -
Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study
by: Navdeep Tangri, et al.
Published: (2021-05-01)